Route 92 Medical

πŸ“ San Mateo, United StatesπŸ—“ Founded 2015πŸ‘₯ 55 employeesπŸ’° Last funded Aug 2019
About Route 92 Medical, Inc. Route 92 Medical is on a mission to improve outcomes for patients undergoing minimally invasive brain procedures. At the core is a reconsidered procedural approach, cutting-edge engineering, and innovative product design. Our portfolio takes aim at the biggest challenges in neurointervention to deliver meaningful solutions to treat challenging diseases such as stroke. Founded by physicians, the company is focused upon developing thoughtful next generation products in collaboration with the world’s leading clinicians with the goal of improving procedural and patient outcomes. The Monopoint operating platform received U.S. FDA 510(k) clearance in 2020. The company is currently enrolling the SUMMIT MAX randomized controlled trial under an FDA-approved Investigational Device Exemption.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2015
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Route 92 Medical?
Route 92 Medical has 1 investors on record on gritt.io, 1 mid-stage.
When did Route 92 Medical last raise funding?
The most recent investment in Route 92 Medical recorded on gritt.io was in August 2019.
When was Route 92 Medical founded?
Route 92 Medical was founded in 2015.
What industry is Route 92 Medical in?
Route 92 Medical operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Route 92 Medical based?
Route 92 Medical is headquartered in San Mateo, United States.